We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Europe Anticipates 200 Million Doses of Pfizer/BioNTech Vaccine in Second Quarter, Commission Says
Europe Anticipates 200 Million Doses of Pfizer/BioNTech Vaccine in Second Quarter, Commission Says
The European Commission has announced that it expects to receive approximately 200 million doses of Pfizer/BioNTech’s two-dose COVID-19 vaccine in the second quarter, giving hope that the EU may reach its inoculation goals on time despite serious setbacks to vaccine deliveries.